Clinical trials
Myositis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2013 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abcuro, Inc. | 1 |
| Allogene Therapeutics | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Janssen Research & Development, LLC | 1 |
| Kite, A Gilead Company | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Pittsburgh | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 10 |
| Dermatomyositis | 4 |
| Polymyositis | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Lupus Nephritis | 2 |
| Muscular Diseases | 2 |
| Myositis, Inclusion Body | 2 |
| Nervous System Diseases | 2 |
| Neuromuscular Diseases | 2 |
| Scleroderma, Systemic | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.